Бончева М. Проучване и анализ на потребностите от клинично-лабораторни изследвания в общата медицинска практика.
Дисертационен труд. 2006 [In English: Investigation and analysis
of clinical and laboratory research needs in general medical practice.
Dissertation work. 2006]
Шишенков М, Томова Д, Генов С, Георгиева А, Кацарска И.
Определяне на глюкоза в капилярна кръв с АВТ GLUCOMETER
Обща Медицина. 2007;2 [In English: Shishenkov M, TomovaDimitrova N, Genev S, Georgieva A, Katsarska I. Determination of glucose in capillary blood samples on ABT GLUCOMETER 3000. General medicine. 2007;2]
Bereznicki L, Jackson S, Peterson G. Supervised patient self-testing of warfarin therapy using an online system. Jmed Internet Res. 2013;15(7): e138.
Dai K, Tai D, Ho P, Chen C, Peng W, Chen S et al. An evaluation
of clinical accuracy of the EasyTouch blood uric acid self-monitoring
system. Clin Biochem. 2005;38(3):278-81.
Deledda J, Fermann G, Lindsell C, Rohlfing R, Gibler B. Cardiav
Point-of-Care Testing: Impact on Emergency Department Door to
Disposition Time is Modified by Patient Acuity and Hospital Setting.
Point of Care. 2011;10(1),1-6.
Du Y, Zhang W, Wang M. An On-Chip Disposable Salivary
Glucose Sensor for Diabetes Control. J Diabetes Sci Technol.
;10(6):1344-1352.
Freedman D. Clinical governance: implications for point-of-care
testing. Ann Clin Biochem. 2002;39:421- 423.
Gallup. Honesty/Ethics in Professions poll. 2013.
http://www.gallup.com/poll/1654/ Honesty-Ethics-Professions.aspx.
Gilbert H, Szokol J. Point of care technologies. Advances in
Bedside. Monitoring and Analysis:2003;73-92.
Ghosh J, Sil P. Arjunolic acid: a new multifunctional therapeutic
promise of alternative medicine. Biochimie. 2013;95(6):1098-1109.
Goble J, Rocafort P. Point-of-Care Testing: Future of Chronic
Disease State Management? J Pharm Pract. 2015;30(2).
Gubbins P, Klepser M, Adams A, Jacobs D, Percival K, Tallman
G. Potential for Pharmacy-Public Health Collaborations Using
Pharmacy-Based Point-of-Care Testing Services for Infectious
Diseases. J Public Health Manag Pract. 2017;23(6):593-600 .
Keffer J. Economic considerations of point-of-care testing. Am J
Clin Pathol. 2005;104(4):107-110.
Kim J, Oh H, Kim A, Kim J, Lee E, Baek J et al. A study on
detection of glucose concentration using changes in color coordinates. Bioengineered. 2017;8(1):99-104.
Kost G. Guidelines for point-of-care testing: improving patient
outcomes. Am J Clin Pathol. 2001;104(4):111-127.
Krouwer J. Why the New FDA Glucose Meter POCT Guidance Is
Disappointing. J Diabetes Sci Technol. 2017;11(6).
Kuchinke W, Aerts J, Semler S, Ohmann C. CDISC standardbased electronic archiving of clinical trials. Methods Inf Med.
;48(5):408–413.
Kwon H, Lee J, Park H, Han K. Evaluation of a novel point-ofcare test kit, ABSOGEN™ PCT, in semi-quantitative measurement of
procalcitonin in whole blood. J Clin Lab Anal. 2017;31(6).
Lee-Lewandrowski E, Laposata M, Eschenbach K, Camooso C,
Nathan D, Godine J et al. Utilization and cost analysis of bedside
capillary glucose testing in a large teaching hospital: implications for
managing point of care testing. Am J Med. 1994;97(3):222-230.
Morgan J. Point of care and patient privacy: Who is in control?
Top Health Inform Manage. 2000;14(4):36-43.
Paraskos J, Berke Z, Cook J, Miner J, Braddock M, Platt A et al.
An analytical comparison between point-of-care uric acid testing
meters. Expert Rev Mol Diagn. 2016;16(3):373-382.
Point-of care testing guidelines.Washington State Clinical
Laboratory Advisory Council. Originally published: October 2000.
Reviewed/Revised: March 2005/March 2009.
Price C. Point of care testing. BMJ. 2001; 322(7297):1285–1288.
Ribet F, Stemme G, Roxhed N. Ultra-miniaturization of a planar
amperometric sensor targeting continuous intradermal glucose
monitoring. Biosens Bioelectron. 2017;90:577-583.
Richter C, Taylor J, Wright J, Fletcher B. Clinical Validation of
R-T Estimation for CoaguChek XS INR Results. Ann Pharmacother.
;50(8):645-648.
